HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad M Al-Sanea Selected Research

Necrosis

11/2020Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide/galactosamine-induced hepatic damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad M Al-Sanea Research Topics

Disease

19Neoplasms (Cancer)
12/2023 - 01/2015
4Edema (Dropsy)
09/2023 - 01/2018
4Breast Neoplasms (Breast Cancer)
12/2022 - 01/2018
3Neoplasm Metastasis (Metastasis)
01/2022 - 01/2021
2Inflammation (Inflammations)
09/2023 - 08/2023
2Wounds and Injuries (Trauma)
11/2022 - 04/2022
2Hepatocellular Carcinoma (Hepatoma)
02/2022 - 12/2020
2Leukemia
01/2022 - 01/2015
2Ulcer
01/2022 - 01/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 08/2014
1Rheumatoid Arthritis
09/2023
1Atherosclerosis
09/2023
1Parkinson Disease (Parkinson's Disease)
08/2023
1Dementia (Dementias)
11/2022
1Virus Diseases (Viral Diseases)
01/2022
1Salmonella Infections (Salmonellosis)
11/2021
1Renal Cell Carcinoma (Grawitz Tumor)
10/2021
1Stomach Ulcer (Gastric Ulcer)
04/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
12/2020
1Necrosis
11/2020
1Psoriatic Arthritis
05/2020
1Chromosome Aberrations (Chromosome Abnormalities)
05/2020
1Stomach Neoplasms (Stomach Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

4CarrageenanIBA
09/2023 - 01/2018
3AntioxidantsIBA
03/2023 - 12/2020
3Antineoplastic Agents (Antineoplastics)IBA
05/2022 - 12/2021
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2022 - 01/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 04/2022
2Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2022 - 01/2015
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2021 - 10/2021
2benzofuranIBA
12/2021 - 05/2020
2Carboxylic AcidsIBA
06/2021 - 05/2020
2Protein Isoforms (Isoforms)IBA
06/2021 - 05/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 08/2014
1Sorafenib (BAY 43-9006)FDA Link
12/2023
1LipidsIBA
09/2023
1LigandsIBA
09/2023
1ChitosanIBA
08/2023
1AlginatesIBA
08/2023
1LipopolysaccharidesIBA
08/2023
1oleuropeinIBA
08/2023
1Monoamine Oxidase (MAO)IBA
08/2023
1OximesIBA
08/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2023
1Anti-Allergic Agents (Antiallergic Agents)IBA
03/2023
1Free Radical ScavengersIBA
03/2023
1NanocapsulesIBA
12/2022
1AluminumIBA
11/2022
1Therapeutic UsesIBA
11/2022
1LuteolinIBA
11/2022
1orientinIBA
11/2022
1CollagenIBA
11/2022
1TriterpenesIBA
05/2022
1Transforming Growth Factor-beta Type I ReceptorIBA
04/2022
1EnzymesIBA
02/2022
1NAD (NADH)IBA
02/2022
1Proteins (Proteins, Gene)FDA Link
02/2022
1Oxidoreductases (Dehydrogenase)IBA
02/2022
1quinone (benzoquinone)IBA
02/2022
1trioctyl phosphine oxide (TOPO)IBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1Celecoxib (Celebrex)FDA Link
01/2022
1Benzoates (Benzoate)IBA
01/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022
1Lim KinasesIBA
01/2022
1Dosage Forms (Dosage Form)IBA
11/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021
1Superoxide DismutaseIBA
11/2021
1Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
11/2021
1tivozanibIBA
10/2021
1SulfonamidesIBA
06/2021
1SulfonesIBA
06/2021
1Indomethacin (Indometacin)FDA LinkGeneric
04/2021
1Cimetidine (Biomet)FDA LinkGeneric
04/2021
1KetonesIBA
01/2021
1IsoenzymesIBA
01/2021
1Liposomes (Liposome)IBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
13-acetylpyridineIBA
01/2021
1tetramethylpyrazineIBA
01/2021
1Propidium (Propidium Iodide)IBA
01/2021
1carbonic anhydrase XIIIBA
01/2021
1ChalconesIBA
01/2021
1Complex MixturesIBA
01/2021
1TubulinIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1SpirooxindolesIBA
12/2020
1Caspase 3 (Caspase-3)IBA
11/2020
1Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2020
1AcidsIBA
05/2020
1Carbonic Anhydrase InhibitorsIBA
05/2020
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
05/2020
1apremilastIBA
05/2020
1Aurora KinasesIBA
01/2020
1Mediator ComplexIBA
01/2020

Therapy/Procedure

5Therapeutics
11/2022 - 01/2020
1Chemoprevention
02/2022
1Complementary Therapies (Alternative Medicine)
11/2021